Lexicon Pharmaceuticals is a fully integrated biopharmaceutical company that is applying a unique approach to gene science based on Nobel Prize-winning technology to discover and develop precise medicines for people with serious, chronic conditions.  All of the Company's drug candidates are new molecular entities discovered internally by its dedicated drug discovery teams and designed to affect particular points on a genetically-defined pathway that can be used to fight a disease process. Lexicon Pharmaceuticals has advanced new therapies across a wide spectrum of human disease, from conditions affecting millions of people, such as diabetes, to carcinoid syndrome.

Type
Public
HQ
Spring, US
Founded
1995
Size (employees)
168 (est)
Lexicon Pharmaceuticals was founded in 1995 and is headquartered in Spring, US
Report incorrect company information

Key People/Management at Lexicon Pharmaceuticals

Raymond Debbane

Raymond Debbane

Chairman of the Board
Pablo Lapuerta

Pablo Lapuerta

Executive Vice President of Clinical Development and Chief Medical Officer
Jeffrey L. Wade

Jeffrey L. Wade

Executive Vice President and Chief Financial Officer
James F. Tessmer

James F. Tessmer

Vice President of Finance and Accounting
Alan J. Main

Alan J. Main

Executive Vice President, Commercial Supply Operations
Lonnel Coats

Lonnel Coats

President and Chief Executive Officer and Director

Lexicon Pharmaceuticals Office Locations

Lexicon Pharmaceuticals has offices in Indianapolis, Jersey, Spring, Orlando and in 27 other locations
Spring, US (HQ)
8800 Technology Forest Place
Show all (31)
Report incorrect company information

Lexicon Pharmaceuticals Financials and Metrics

Lexicon Pharmaceuticals Financials

Lexicon Pharmaceuticals's revenue was reported to be $90.34 m in FY, 2017
USD

Revenue (Q1, 2018)

25.2 m

Gross profit (Q1, 2018)

24.7 m

Gross profit margin (Q1, 2018), %

97.9%

Net income (Q1, 2018)

(42.1 m)

EBIT (Q1, 2018)

(38 m)

Market capitalization (14-Jun-2018)

1.4 b

Closing share price (14-Jun-2018)

12.9

Cash (31-Mar-2018)

20.4 m
Lexicon Pharmaceuticals's current market capitalization is $1.4 b.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

2.2 m22.9 m130 m83.3 m90.3 m

Revenue growth, %

929%469%(36%)

Cost of goods sold

1.9 m

Gross profit

88.4 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Revenue

238 k277 k676 k419 k1.8 m376 k566 k20.1 m27.7 m18.3 m12.1 m26.9 m25.2 m

Cost of goods sold

225 k537 k599 k533 k

Gross profit

18.1 m11.5 m26.3 m24.7 m

Gross profit Margin, %

99%96%98%98%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2017

Cash

37.5 m137.3 m46.6 m61.7 m

Inventories

1.9 m

Current Assets

134.6 m369 m357.9 m322 m

Goodwill

44.5 m44.5 m44.5 m44.5 m
Quarterly
USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Cash

9.7 m61.7 m24.7 m38.4 m38.8 m2.5 m30.7 m83.3 m20.4 m

Accounts Receivable

(3.1 m)

Inventories

236 k811 k4.5 m2.1 m

Current Assets

313.8 m288.9 m492.2 m439.5 m398.7 m279.1 m247.2 m214 m273.2 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2017

Depreciation and Amortization

2.1 m3.4 m

Inventories

(1.9 m)

Cash From Operating Activities

(91.1 m)(75.6 m)(175.6 m)(185.4 m)

Purchases of PP&E

(1.7 m)(80 k)(231 k)(228 k)
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Net Income

(34.9 m)(73 m)(109 m)(34.9 m)(70 m)(30.7 m)(42.1 m)

Depreciation and Amortization

2.2 m644 k1.2 m1.7 m355 k601 k661 k521 k1 m1.5 m634 k1.6 m925 k

Inventories

4.5 m

Accounts Payable

52.6 m
USDY, 2018

Financial Leverage

14.8 x
Show all financial metrics

Lexicon Pharmaceuticals Operating Metrics

FY, 2016

Phase I Trials Products

1

Phase III Trials Products

2

Preclinical Phase Products

1

Products

1
Show all operating metrics
Report incorrect company information

Lexicon Pharmaceuticals Online and Social Media Presence

Embed Graph
Report incorrect company information

Lexicon Pharmaceuticals News and Updates

Report incorrect company information